|
|
Issuer: Sangui BioTech International Inc.
/ Key words: 9 Month figures
Sangui BioTech International Inc.: Significant increase in sales in the first three quarters of the year Further reduction of the operating loss
15.05.2023 / 09:48 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Sangui BioTech International Inc.
/ Key words: Half Year Results
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year Further reduction of the operating loss
13.02.2023 / 09:11 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Sangui BioTech International Inc.
/ Key words: Quarter Results
Sangui BioTech International Inc.: Sales of USD 41,029 in first quarter For the first time, positive quarterly result in the companys history
11.11.2022 / 10:56 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Sangui BioTech International Inc.
/ Key words: Development of Sales
Sangui BioTech International Inc.: Increase in sales in the first quarter of 121% Highest quarterly sales in the companys history
12.10.2022 / 12:57 CET/CEST
The issuer is solely responsible for the content of this announcement.
Sangui... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Sangui BioTech International Inc.
/ Key words: Annual Results
Sangui BioTech International Inc.: Sales of USD 69,190 in fiscal year 2022 Reduction of the operating loss
29.09.2022 / 10:54 CET/CEST
The issuer is solely responsible for the content of this announcement.
Sangui B... Lire le communiqué |
|
| |
|
| |
|
|
Issuer: Sangui BioTech International Inc.
/ Key words: 9 Month figures
Sangui BioTech International Inc.: Increase in sales in the first nine months of the year Further reduction of the operating loss
17.05.2022 / 08:36
The issuer is solely responsible for the content of this announcement.
... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Sangui BioTech International Inc.
/ Key words: Quarter Results
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year Further reduction of the operating loss
16.02.2022 / 09:15
The issuer is solely responsible for the content of this announcement.
Sangui BioTech... Lire le communiqué |
|
| |
|
| |
